Health Canada has given the thumbs up to a local company to produce cannabis.
AgMedica Bioscience Inc. received the licence under the Access to Cannabis for Medical Purposes Regulation.
In the coming weeks, the company is planning to begin cultivation in the first phase of its indoor Riverview Cultivation Facility with a current annual production capacity of 6,000 kilograms.
“This is another major accomplishment in the growth of AgMedica. The management team is pleased to have achieved this critical milestone and would like to thank all of our employees, partners, and shareholders for their efforts and continued support.” said Art Vander Pol, CEO, in a media release. “We believe that AgMedica has one of the largest, if not the largest, initial capacity of any newly licensed producer of cannabis in Canada. While we are celebrating this accomplishment, we realize this is just one more milestone on our journey to become a global leader in cannabis production as well as the development and commercialization of cannabis-derived products that positively impacts the health and well-being of our customers.”
AgMedica has assembled a management team with decades of experience in large-scale commercial agriculture and in the development and commercialization of pharmaceutical products.
